{"id":4813,"date":"2026-04-16T22:34:12","date_gmt":"2026-04-16T22:34:12","guid":{"rendered":"https:\/\/fehv.org\/?p=4813"},"modified":"2026-04-16T22:34:14","modified_gmt":"2026-04-16T22:34:14","slug":"diuretic-drug-spironolactone-and-fatty-liver","status":"publish","type":"post","link":"https:\/\/fehv.org\/en\/diuretic-drug-spironolactone-and-fatty-liver\/","title":{"rendered":"Diuretic drug: Spironolactone and fatty liver"},"content":{"rendered":"\n<p style=\"font-size:18px\">Approximately 30% of the world&#8217;s population has fatty liver disease, which represents a major public health problem in any country, as this disease can lead to liver cirrhosis and is associated with cardiovascular diseases such as high blood pressure.<\/p>\n\n\n\n<p style=\"font-size:18px\">High blood pressure is also a major health problem that affects approximately one-third of the world&#8217;s adult population and is frequently treated with a diuretic drug called spironolactone. There is experimental evidence suggesting that <strong>this drug can reduce fat accumulation in the liver<\/strong> and slow the progression of liver fibrosis.<\/p>\n\n\n\n<p style=\"font-size:18px\">A study has been published in the <strong><a href=\"https:\/\/journals.lww.com\/eurojgh\/pages\/default.aspx\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">European Journal of Gastroenterology and Hepatology<\/a><\/strong> examining the potential beneficial effect of spironolactone treatment on fatty liver disease. A total of 4110 participants with high blood pressure were included, of whom 822 were treated with spironolactone for six consecutive months. To diagnose possible fatty liver disease, patients underwent an annual <strong><a href=\"https:\/\/fehv.org\/en\/diagnoses-and-treatments\/abdominal-ultrasound\/\">abdominal ultrasound<\/a><\/strong>. The risk of developing fatty liver was found to be significantly reduced (18%) in patients with high blood pressure treated with spironolactone compared to those not taking the drug. <\/p>\n\n\n\n<h2 class=\"wp-block-heading mt-5 mb-4\" id=\"h-usefulness-of-spironolactone-in-the-treatment\"><strong>Usefulness of spironolactone in the treatment<\/strong><\/h2>\n\n\n\n<p style=\"font-size:18px\">It was also found that increasing the drug dose by 100 mg decreased the risk of developing fatty liver disease by 7.4%. Furthermore, when the cumulative dose of spironolactone was 635 mg, the risk of developing fatty liver disease decreased by 72%.<\/p>\n\n\n\n<p style=\"font-size:18px\">In summary, <strong>the study confirms that spironolactone treatment may be useful<\/strong> in patients with high blood pressure to reduce the risk of developing fatty liver disease and, if necessary, to treat this disease.<\/p>\n\n\n\n<p style=\"font-size:18px\"><strong><a href=\"\/en\/especialista\/dr-vicente-carreno\/\">Dr. Carre\u00f1o<\/a><\/strong> and the Foundation&#8217;s doctors agree with the potential usefulness of this drug in the treatment of fatty liver disease. However, we believe that further studies are needed, expanding the number of patients to include other ethnic groups (the study was only conducted with a Chinese population) and possibly even conducting a study demonstrating the impact of spironolactone treatment on liver biopsies from patients with fatty liver.<\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"A study shows spironolactone reduces fatty liver risk in patients with hypertension, lowering liver fat accumulation and slowing fibrosis progression.","protected":false},"author":1,"featured_media":4811,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[623,621,624],"tags":[],"class_list":["post-4813","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fatty-liver","category-news","category-treatments"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.7 (Yoast SEO v23.7) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Diuretic drug: Spironolactone and fatty liver - Cl\u00ednica FEHV<\/title>\n<meta name=\"description\" content=\"Spironolactone fatty liver treatment may reduce disease risk; learn its benefits in patients with liver fat accumulation.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fehv.org\/en\/diuretic-drug-spironolactone-and-fatty-liver\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Diuretic drug: Spironolactone and fatty liver\" \/>\n<meta property=\"og:description\" content=\"Spironolactone fatty liver treatment may reduce disease risk; learn its benefits in patients with liver fat accumulation.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fehv.org\/en\/diuretic-drug-spironolactone-and-fatty-liver\/\" \/>\n<meta property=\"og:site_name\" content=\"Cl\u00ednica FEHV\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/pages\/Fundacion%20Para%20el%20Estudio%20de%20las%20Hepatitis%20Virales\/228605694153917\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-16T22:34:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-16T22:34:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fehv.org\/wp-content\/uploads\/2026\/04\/espironolactona-higado-graso.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1281\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"ifranco\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ifranco\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/fehv.org\/en\/diuretic-drug-spironolactone-and-fatty-liver\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/fehv.org\/en\/diuretic-drug-spironolactone-and-fatty-liver\/\"},\"author\":{\"name\":\"ifranco\",\"@id\":\"https:\/\/fehv.org\/#\/schema\/person\/5e92ddd4a04516dab21fb5b6fa90b777\"},\"headline\":\"Diuretic drug: Spironolactone and fatty liver\",\"datePublished\":\"2026-04-16T22:34:12+00:00\",\"dateModified\":\"2026-04-16T22:34:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/fehv.org\/en\/diuretic-drug-spironolactone-and-fatty-liver\/\"},\"wordCount\":325,\"publisher\":{\"@id\":\"https:\/\/fehv.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/fehv.org\/en\/diuretic-drug-spironolactone-and-fatty-liver\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/fehv.org\/wp-content\/uploads\/2026\/04\/espironolactona-higado-graso.jpg\",\"articleSection\":[\"Fatty liver\",\"News\",\"Treatments\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fehv.org\/en\/diuretic-drug-spironolactone-and-fatty-liver\/\",\"url\":\"https:\/\/fehv.org\/en\/diuretic-drug-spironolactone-and-fatty-liver\/\",\"name\":\"Diuretic drug: Spironolactone and fatty liver - Cl\u00ednica FEHV\",\"isPartOf\":{\"@id\":\"https:\/\/fehv.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/fehv.org\/en\/diuretic-drug-spironolactone-and-fatty-liver\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/fehv.org\/en\/diuretic-drug-spironolactone-and-fatty-liver\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/fehv.org\/wp-content\/uploads\/2026\/04\/espironolactona-higado-graso.jpg\",\"datePublished\":\"2026-04-16T22:34:12+00:00\",\"dateModified\":\"2026-04-16T22:34:14+00:00\",\"description\":\"Spironolactone fatty liver treatment may reduce disease risk; learn its benefits in patients with liver fat accumulation.\",\"breadcrumb\":{\"@id\":\"https:\/\/fehv.org\/en\/diuretic-drug-spironolactone-and-fatty-liver\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fehv.org\/en\/diuretic-drug-spironolactone-and-fatty-liver\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fehv.org\/en\/diuretic-drug-spironolactone-and-fatty-liver\/#primaryimage\",\"url\":\"https:\/\/fehv.org\/wp-content\/uploads\/2026\/04\/espironolactona-higado-graso.jpg\",\"contentUrl\":\"https:\/\/fehv.org\/wp-content\/uploads\/2026\/04\/espironolactona-higado-graso.jpg\",\"width\":1920,\"height\":1281,\"caption\":\"Espironolactona para higado graso\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/fehv.org\/en\/diuretic-drug-spironolactone-and-fatty-liver\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/fehv.org\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Diuretic drug: Spironolactone and fatty liver\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/fehv.org\/#website\",\"url\":\"https:\/\/fehv.org\/\",\"name\":\"Cl\u00ednica FEHV\",\"description\":\"Web de la Cl\u00ednica de la Fundaci\u00f3n para el Estudio de las Hepatitis Virales\",\"publisher\":{\"@id\":\"https:\/\/fehv.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/fehv.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/fehv.org\/#organization\",\"name\":\"Fundaci\u00f3n para el Estudio de las Hepatitis Virales - FEHV\",\"url\":\"https:\/\/fehv.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fehv.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/fehv.org\/wp-content\/uploads\/2021\/03\/logo_fib-4.png\",\"contentUrl\":\"https:\/\/fehv.org\/wp-content\/uploads\/2021\/03\/logo_fib-4.png\",\"width\":47,\"height\":73,\"caption\":\"Fundaci\u00f3n para el Estudio de las Hepatitis Virales - FEHV\"},\"image\":{\"@id\":\"https:\/\/fehv.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/pages\/Fundacion Para el Estudio de las Hepatitis Virales\/228605694153917\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/fehv.org\/#\/schema\/person\/5e92ddd4a04516dab21fb5b6fa90b777\",\"name\":\"ifranco\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fehv.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/aa877054d0216c55e7104c50647e81a8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/aa877054d0216c55e7104c50647e81a8?s=96&d=mm&r=g\",\"caption\":\"ifranco\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Diuretic drug: Spironolactone and fatty liver - Cl\u00ednica FEHV","description":"Spironolactone fatty liver treatment may reduce disease risk; learn its benefits in patients with liver fat accumulation.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fehv.org\/en\/diuretic-drug-spironolactone-and-fatty-liver\/","og_locale":"en_US","og_type":"article","og_title":"Diuretic drug: Spironolactone and fatty liver","og_description":"Spironolactone fatty liver treatment may reduce disease risk; learn its benefits in patients with liver fat accumulation.","og_url":"https:\/\/fehv.org\/en\/diuretic-drug-spironolactone-and-fatty-liver\/","og_site_name":"Cl\u00ednica FEHV","article_publisher":"https:\/\/www.facebook.com\/pages\/Fundacion%20Para%20el%20Estudio%20de%20las%20Hepatitis%20Virales\/228605694153917\/","article_published_time":"2026-04-16T22:34:12+00:00","article_modified_time":"2026-04-16T22:34:14+00:00","og_image":[{"width":1920,"height":1281,"url":"https:\/\/fehv.org\/wp-content\/uploads\/2026\/04\/espironolactona-higado-graso.jpg","type":"image\/jpeg"}],"author":"ifranco","twitter_card":"summary_large_image","twitter_misc":{"Written by":"ifranco","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fehv.org\/en\/diuretic-drug-spironolactone-and-fatty-liver\/#article","isPartOf":{"@id":"https:\/\/fehv.org\/en\/diuretic-drug-spironolactone-and-fatty-liver\/"},"author":{"name":"ifranco","@id":"https:\/\/fehv.org\/#\/schema\/person\/5e92ddd4a04516dab21fb5b6fa90b777"},"headline":"Diuretic drug: Spironolactone and fatty liver","datePublished":"2026-04-16T22:34:12+00:00","dateModified":"2026-04-16T22:34:14+00:00","mainEntityOfPage":{"@id":"https:\/\/fehv.org\/en\/diuretic-drug-spironolactone-and-fatty-liver\/"},"wordCount":325,"publisher":{"@id":"https:\/\/fehv.org\/#organization"},"image":{"@id":"https:\/\/fehv.org\/en\/diuretic-drug-spironolactone-and-fatty-liver\/#primaryimage"},"thumbnailUrl":"https:\/\/fehv.org\/wp-content\/uploads\/2026\/04\/espironolactona-higado-graso.jpg","articleSection":["Fatty liver","News","Treatments"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/fehv.org\/en\/diuretic-drug-spironolactone-and-fatty-liver\/","url":"https:\/\/fehv.org\/en\/diuretic-drug-spironolactone-and-fatty-liver\/","name":"Diuretic drug: Spironolactone and fatty liver - Cl\u00ednica FEHV","isPartOf":{"@id":"https:\/\/fehv.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fehv.org\/en\/diuretic-drug-spironolactone-and-fatty-liver\/#primaryimage"},"image":{"@id":"https:\/\/fehv.org\/en\/diuretic-drug-spironolactone-and-fatty-liver\/#primaryimage"},"thumbnailUrl":"https:\/\/fehv.org\/wp-content\/uploads\/2026\/04\/espironolactona-higado-graso.jpg","datePublished":"2026-04-16T22:34:12+00:00","dateModified":"2026-04-16T22:34:14+00:00","description":"Spironolactone fatty liver treatment may reduce disease risk; learn its benefits in patients with liver fat accumulation.","breadcrumb":{"@id":"https:\/\/fehv.org\/en\/diuretic-drug-spironolactone-and-fatty-liver\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fehv.org\/en\/diuretic-drug-spironolactone-and-fatty-liver\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fehv.org\/en\/diuretic-drug-spironolactone-and-fatty-liver\/#primaryimage","url":"https:\/\/fehv.org\/wp-content\/uploads\/2026\/04\/espironolactona-higado-graso.jpg","contentUrl":"https:\/\/fehv.org\/wp-content\/uploads\/2026\/04\/espironolactona-higado-graso.jpg","width":1920,"height":1281,"caption":"Espironolactona para higado graso"},{"@type":"BreadcrumbList","@id":"https:\/\/fehv.org\/en\/diuretic-drug-spironolactone-and-fatty-liver\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/fehv.org\/en\/"},{"@type":"ListItem","position":2,"name":"Diuretic drug: Spironolactone and fatty liver"}]},{"@type":"WebSite","@id":"https:\/\/fehv.org\/#website","url":"https:\/\/fehv.org\/","name":"Cl\u00ednica FEHV","description":"Web de la Cl\u00ednica de la Fundaci\u00f3n para el Estudio de las Hepatitis Virales","publisher":{"@id":"https:\/\/fehv.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fehv.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/fehv.org\/#organization","name":"Fundaci\u00f3n para el Estudio de las Hepatitis Virales - FEHV","url":"https:\/\/fehv.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fehv.org\/#\/schema\/logo\/image\/","url":"https:\/\/fehv.org\/wp-content\/uploads\/2021\/03\/logo_fib-4.png","contentUrl":"https:\/\/fehv.org\/wp-content\/uploads\/2021\/03\/logo_fib-4.png","width":47,"height":73,"caption":"Fundaci\u00f3n para el Estudio de las Hepatitis Virales - FEHV"},"image":{"@id":"https:\/\/fehv.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/pages\/Fundacion Para el Estudio de las Hepatitis Virales\/228605694153917\/"]},{"@type":"Person","@id":"https:\/\/fehv.org\/#\/schema\/person\/5e92ddd4a04516dab21fb5b6fa90b777","name":"ifranco","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fehv.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/aa877054d0216c55e7104c50647e81a8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/aa877054d0216c55e7104c50647e81a8?s=96&d=mm&r=g","caption":"ifranco"}}]}},"_links":{"self":[{"href":"https:\/\/fehv.org\/en\/wp-json\/wp\/v2\/posts\/4813"}],"collection":[{"href":"https:\/\/fehv.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fehv.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fehv.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fehv.org\/en\/wp-json\/wp\/v2\/comments?post=4813"}],"version-history":[{"count":1,"href":"https:\/\/fehv.org\/en\/wp-json\/wp\/v2\/posts\/4813\/revisions"}],"predecessor-version":[{"id":4814,"href":"https:\/\/fehv.org\/en\/wp-json\/wp\/v2\/posts\/4813\/revisions\/4814"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fehv.org\/en\/wp-json\/wp\/v2\/media\/4811"}],"wp:attachment":[{"href":"https:\/\/fehv.org\/en\/wp-json\/wp\/v2\/media?parent=4813"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fehv.org\/en\/wp-json\/wp\/v2\/categories?post=4813"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fehv.org\/en\/wp-json\/wp\/v2\/tags?post=4813"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}